search
Back to results

Safety and Feasibility of ExoNET

Primary Purpose

Stroke, Cerebral Vascular Accident

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
ExoNet Tuned to Gravity Support
Sponsored by
Shirley Ryan AbilityLab
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stroke focused on measuring Upper Extremity, Rehabilitation, Stroke

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Ischemic or hemorrhagic stroke (8 months post stroke)
  2. Available medical records and radiographic information about lesion locations
  3. Hemiparesis
  4. Some degree of both shoulder and elbow movement capability
  5. A "moderate" impairment (Fugl-Meyer score between 15-50)

Exclusion Criteria:

  1. Individuals under the age of 18
  2. Bilateral paresis
  3. Shoulder pain and/or articular rigidity on the upper limb joint
  4. Spasticity (Modified Ashworth Scale of 2)
  5. Botox injection to the affected upper extremity within the previous 4 months
  6. Aphasia, cognitive impairment, or affective dysfunction that would influence the ability to perform the experiment

Sites / Locations

  • Shirley Ryan AbilityLabRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

Experimental Group: Gravity Compensation

Control Group: No Gravity Compensation

Arm Description

The participants will be wearing the ExoNet device tuned to gravity support.

The participants will be wearing the ExoNet device, but it will not be tuned to gravity support.

Outcomes

Primary Outcome Measures

Action Research Arm Test
observational measure used to assess change in upper extremity performance in individuals with a damaged nervous system

Secondary Outcome Measures

Fugl-Meyer
observational measure used to measure change in upper extremity impairment in individuals with a damaged nervous system
Wolf Motor Function Test
Quantitative measure of change of upper extremity motor ability
Box and Blocks
Measures change in unilateral gross motor dexterity

Full Information

First Posted
December 5, 2021
Last Updated
October 10, 2023
Sponsor
Shirley Ryan AbilityLab
search

1. Study Identification

Unique Protocol Identification Number
NCT05180812
Brief Title
Safety and Feasibility of ExoNET
Official Title
Safety and Feasibility of Upper Extremity ExoNET Support Post Stroke
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 1, 2022 (Actual)
Primary Completion Date
July 12, 2023 (Actual)
Study Completion Date
July 12, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Shirley Ryan AbilityLab

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to evaluate the safety, feasibility, and preliminary efficacy of the ExoNET passive robotic device. It will provide upper-extremity gravity compensation for therapeutic movement retraining in the chronic post stroke patient population.
Detailed Description
The ExoNET, a passive robotic solution that provides a soft, biomimetic, and elastic alternative to robotics that embodies intelligence within the mechanical design. Several groups have been exploring performance enhancement using springs with custom-tuned parameters via optimization. Here, it is possible to have a simple reconfigurable system that can not only assist performance, but can also make training easier, faster, and more complete. This contribution has the potential to be clinically significant for rehabilitating neurologically impaired individuals because this proposal will investigate how motor learning can be facilitated through novel assistive technology. The primary objective of this study is to evaluate the safety, feasibility and efficacy using the ExoNET. Specifically, investigators want to see if the ExoNET tuned to gravity support will lead to a reduction in bicep muscle activity and an increase in range of motion. To accomplish this aim, we plan to have participants perform reaching, arm elevation and flexion task exercises wearing the ExoNET. To achieve these goals, we will use a wearable activity tracker (MiGo), to detect the number of activities performed, a wearable surface EMG system (Delsys) on the bicep muscles and a markerless system called the Kinect (version 2) to collect distribution of motion. Investigators hypothesize that individuals with post-stroke arm movement deficits treated with ExoNET gravity compensation will improve their ARAT measures more than controls receiving a sham treatment. Secondarily, treated subjects will improve in other clinical metrics and will make more movements than controls.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke, Cerebral Vascular Accident
Keywords
Upper Extremity, Rehabilitation, Stroke

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
20 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Experimental Group: Gravity Compensation
Arm Type
Experimental
Arm Description
The participants will be wearing the ExoNet device tuned to gravity support.
Arm Title
Control Group: No Gravity Compensation
Arm Type
Sham Comparator
Arm Description
The participants will be wearing the ExoNet device, but it will not be tuned to gravity support.
Intervention Type
Device
Intervention Name(s)
ExoNet Tuned to Gravity Support
Intervention Description
This study's primary goal is to test the safety, feasibility, and efficacy of the ExoNET device developed in the Robotics Lab at the Shirley Ryan AbilityLab. We want to observe if individuals using the ExoNET tuned to gravity support will notice a reduction in bicep muscle activity, leading to an improvement in functional outcome measures in stroke patients.
Primary Outcome Measure Information:
Title
Action Research Arm Test
Description
observational measure used to assess change in upper extremity performance in individuals with a damaged nervous system
Time Frame
Tested at week 1 (baseline evaluations), week 4 (post evaluations), and week 9 (follow-up evaluations)
Secondary Outcome Measure Information:
Title
Fugl-Meyer
Description
observational measure used to measure change in upper extremity impairment in individuals with a damaged nervous system
Time Frame
Tested at week 1 (baseline evaluations), week 4 (post evaluations), and week 9 (follow-up evaluations)
Title
Wolf Motor Function Test
Description
Quantitative measure of change of upper extremity motor ability
Time Frame
Tested at week 1 (baseline evaluations), week 4 (post evaluations), and week 9 (follow-up evaluations)
Title
Box and Blocks
Description
Measures change in unilateral gross motor dexterity
Time Frame
Tested at week 1 (baseline evaluations), week 4 (post evaluations), and week 9 (follow-up evaluations)
Other Pre-specified Outcome Measures:
Title
Electromyography using Delsys
Description
Delsys sensors will be used to measure change in biceps activity
Time Frame
Treatment phases (week 2 and week 3)
Title
Kinect
Description
markerless system to collect changes of distribution of motion
Time Frame
Treatment phases (week 2 and week 3)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Ischemic or hemorrhagic stroke (8 months post stroke) Available medical records and radiographic information about lesion locations Hemiparesis Some degree of both shoulder and elbow movement capability A "moderate" impairment (Fugl-Meyer score between 15-50) Exclusion Criteria: Individuals under the age of 18 Bilateral paresis Shoulder pain and/or articular rigidity on the upper limb joint Spasticity (Modified Ashworth Scale of 2) Botox injection to the affected upper extremity within the previous 4 months Aphasia, cognitive impairment, or affective dysfunction that would influence the ability to perform the experiment
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Courtney Celian
Phone
3122381560
Email
ccelian@sralab.org
Facility Information:
Facility Name
Shirley Ryan AbilityLab
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60610
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Courtney Celian, MSOT
Phone
312-238-1560
Email
ccelian@sralab.org

12. IPD Sharing Statement

Citations:
PubMed Identifier
21261965
Citation
Gijbels D, Lamers I, Kerkhofs L, Alders G, Knippenberg E, Feys P. The Armeo Spring as training tool to improve upper limb functionality in multiple sclerosis: a pilot study. J Neuroeng Rehabil. 2011 Jan 24;8:5. doi: 10.1186/1743-0003-8-5.
Results Reference
background
PubMed Identifier
27646624
Citation
Lannin NA, Cusick A, Hills C, Kinnear B, Vogel K, Matthews K, Bowring G. Upper limb motor training using a Saebo orthosis is feasible for increasing task-specific practice in hospital after stroke. Aust Occup Ther J. 2016 Dec;63(6):364-372. doi: 10.1111/1440-1630.12330. Epub 2016 Sep 19.
Results Reference
background
Citation
Reichenfelser, W., Gföhler, M., & Karner, J. (2012). Design concept for a mobile arm support. Gait & Posture, (36), S77.
Results Reference
background
Citation
Ryali, P., Carella, T., McDermed, D., Perizes, V., Huang, F., & Patton, J. (2020). A Theoretical Framework for a Network of Elastic Elements Generating Arbitrary Torque Fields. In 2020 8th IEEE RAS/EMBS International Conference for Biomedical Robotics and Biomechatronics (BioRob) (pp. 286-291). IEEE.
Results Reference
background

Learn more about this trial

Safety and Feasibility of ExoNET

We'll reach out to this number within 24 hrs